- Home
- CDXS vs RZLT Comparison
CDXS vs RZLT Comparison
Compare CDXS & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- RZLT
- Stock Information
- Founded
- CDXS 2002
- RZLT 2010
- Country
- CDXS United States
- RZLT United States
- Employees
- CDXS N/A
- RZLT N/A
- Industry
- CDXS Major Chemicals
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- CDXS Industrials
- RZLT Health Care
- Exchange
- CDXS Nasdaq
- RZLT Nasdaq
- Market Cap
- CDXS 332.0M
- RZLT 292.0M
- IPO Year
- CDXS 2010
- RZLT N/A
- Fundamental
- Price
- CDXS $5.28
- RZLT $4.39
- Analyst Decision
- CDXS Buy
- RZLT Strong Buy
- Analyst Count
- CDXS 2
- RZLT 8
- Target Price
- CDXS $11.00
- RZLT $11.63
- AVG Volume (30 Days)
- CDXS 875.4K
- RZLT 388.5K
- Earning Date
- CDXS 10-31-2024
- RZLT 02-11-2025
- Dividend Yield
- CDXS N/A
- RZLT N/A
- EPS Growth
- CDXS N/A
- RZLT N/A
- EPS
- CDXS N/A
- RZLT N/A
- Revenue
- CDXS $64,446,000.00
- RZLT N/A
- Revenue This Year
- CDXS N/A
- RZLT N/A
- Revenue Next Year
- CDXS $2.02
- RZLT N/A
- P/E Ratio
- CDXS N/A
- RZLT N/A
- Revenue Growth
- CDXS N/A
- RZLT N/A
- 52 Week Low
- CDXS $2.53
- RZLT $0.88
- 52 Week High
- CDXS $6.08
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- CDXS 59.97
- RZLT 37.77
- Support Level
- CDXS $5.42
- RZLT $4.07
- Resistance Level
- CDXS $6.01
- RZLT $4.64
- Average True Range (ATR)
- CDXS 0.39
- RZLT 0.36
- MACD
- CDXS -0.05
- RZLT -0.07
- Stochastic Oscillator
- CDXS 46.67
- RZLT 21.92
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.